Search clinical trials for: ACP-104

Total 9287 results

PhotonMD, Inc

Completed

Modulated Light Therapy in Participants With Pattern Hair Loss

Androgenetic Alopecia

Australia
ACADIA Pharmaceuticals Inc.

Completed

ACP-104 in Acutely Psychotic Subjects With Schizophrenia

Schizophrenia

United States
Otsuka Pharmaceutical Co., Ltd.

Completed

A Phase 1 Study of OCV-C02 in Patients With Advanced or Relapsed Colorectal Cancer

Colorectal Cancer

Japan
ACADIA Pharmaceuticals Inc.

Recruiting

ACP-204 in Adults With Alzheimer's Disease Psychosis

Alzheimer's Disease Psychosis

United States
University of Texas Southwestern Medical Center
Stanley Medical Research Institute; ACADIA Pharmaceuticals Inc.

Completed

Safety Study of ACP-104: To Demonstrate the Safety, Tolerability, and Pharmacokinetics (ACP-104)

Schizophrenia

United States
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Examine the Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-ascending Doses of ACT-1014-6470 in Healthy Subjects

Healthy

Netherlands
Seoul National University Hospital
National Evidence-Based Healthcare Collaborating Agency; National Clinical... and other collaborators

Completed

Efficacy of Self-education Program for Advanced Care Planning(RCT) for General Population

Healthy

Korea, Republic of
University of Oxford

Completed

A BCG Challenge Model Study to Assess Anti-mycobacterial Immunity Induced by BCG and a Candidate TB Vaccine, MVA85A

Tuberculosis

United Kingdom
Click Therapeutics, Inc.

Active, not recruiting

An Exploratory Study to Evaluate a Digital Intervention to Disrupt Scratching in Atopic Dermatitis and Psoriasis

Psoriasis | Atopic Dermatitis

United States
Adamis Pharmaceuticals Corporation

Unknown

Dose-Escalation and Safety Study of APC-100 for the Treatment of Prostate Cancer

Prostate Cancer

United States
Click Therapeutics, Inc.

Recruiting

An Exploratory Study to Evaluate Attention Biases in Adults With Multiple Sclerosis, Breast Cancer, and Lung Cancer

Multiple Sclerosis | Breast Cancer | Lung Cancer

United States
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of ACT-1004-1239 in Healthy Male Subjects

Healthy

United States
Idorsia Pharmaceuticals Ltd.

Completed

A Placebo-controlled Phase 1 Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-ascending Doses of ACT-1014-6470 in Healthy Subjects

Healthy

Germany
Idorsia Pharmaceuticals Ltd.

Completed

Study in Healthy Subjects to Examine the Safety and Tolerability of ACT-1004-1239 Given as Multiple, Gradually Increasing Doses and to Examine the Effects of ACT-1004-1239 on the Body and the Way the Body Takes up, Distributes, and Gets Rid of ACT-1004-1239

Healthy

Portugal
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Investigate the Pharmacokinetics of ACT-1014-6470 in Subjects With Severe Renal Impairment Compared to Control Subjects

Healthy

Germany
Catapult Therapeutics

Recruiting

CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia

Lymphocytic Leukemia, Chronic | SLL

United States, Spain
Transwell Biotech Co., Ltd.

Completed

TWB-103 for Treating Lower Limb Ulcers on Patients With DM

Diabetic Foot Ulcer

Taiwan
The Hong Kong Polytechnic University
Tuen Mun Hospital

Recruiting

Program Using a Mobile Application Versus Telephone Advice on Patients at Risk of Coronary Heart Disease : a Pilot RCT

Coronary Heart Disease

Hong Kong
Transposon Therapeutics, Inc.

Active, not recruiting

A Phase 2a Study of TPN-101 in Patients With Progressive Supranuclear Palsy (PSP)

Progressive Supranuclear Palsy

United States
Utah State University

Completed

Open Trial of an ACT Skills Group and Mobile App for Worry

Generalized Anxiety Disorder

United States
Idorsia Pharmaceuticals Ltd.

Completed

Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-389949

Healthy Subjects

Netherlands
ACADIA Pharmaceuticals Inc.

Recruiting

Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome

Hyperphagia in Prader-Willi Syndrome

United States, Canada
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Assess the Tolerability, Safety, Pharmacodynamics, and Pharmacokinetics of Ascending Single Doses (Including Food Interaction) and Ascending Multiple Doses of ACT-453859, and Multiple Doses of Setipiprant (ACT-129968)

Healthy
Idorsia Pharmaceuticals Ltd.

Terminated

A Study in Healthy Subjects to Investigate the Safety and Tolerability of ACT- 541478 as Well as What ACT-541478 Does to the Body and the Way the Body Takes up, Distributes, and Gets Rid of ACT-541478

Healthy

Germany
The Hong Kong Polytechnic University
United Christian Hospital; Shatin Hospital; Bradbury Hospice

Recruiting

ACP-Family Programme for Palliative Care Patients and Their Family Member

Palliative Care

Hong Kong
Helios Albert-Schweitzer-Klinik Northeim

Completed

Endocuff-assisted Versus Cap-assisted Versus Standard Colonoscopy (EC-Cap-SC)

Colorectal Polyps | Colorectal Adenomas

Germany, Poland
Midnight Pharma, LLC

Completed

Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia

Chronic Primary Insomnia

United States
Fred Hutchinson Cancer Center
National Institute on Drug Abuse (NIDA)

Active, not recruiting

A Smartphone Application (ACT on Vaping) for Vaping Cessation in Young Adults

Nicotine Dependence | Nicotine Use Disorder | Nicotine Vaping | Vaping | Nicotine Addiction

United States
Duke-NUS Graduate Medical School
Singapore General Hospital; National Heart Centre Singapore

Completed

Impact of Advance Care Planning on Care for Patients With Advanced Heart Failure

Heart Failure

Singapore
Sunovion Respiratory Development Inc.

Completed

A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (GOLDEN-2)

COPD

United States
Nordsjaellands Hospital
Odense University Hospital; Zealand University Hospital; Rigshospitalet, Denmark and other collaborators

Completed

Advance Care Planning in Patients With Heart Failure in Denmark (DanHFacp)

Heart Failure | Communication | Feasibility Studies | Advance Care Planning

Denmark
Schulthess Klinik
Arthrex, Inc.

Completed

Rotator Cuff Reconstruction With Xenologous Dermis-patch Augmentation and ACP® - Injection

Rotator Cuff Tears

Switzerland
ACADIA Pharmaceuticals Inc.

Completed

Evaluate the Efficacy and Safety of ACP-044 for the Treatment of Acute Postoperative Pain Following Bunionectomy

Acute Postoperative Pain | Bunionectomy

United States
ACADIA Pharmaceuticals Inc.

Terminated

Evaluate the Efficacy and Safety of ACP-044 in Subjects With Pain Associated With Osteoarthritis of the Knee

Osteoarthritis Pain

United States
University of California, San Francisco
National Institute on Aging (NIA)

Recruiting

Advance Care Planning With Formerly Homeless Older Adults Residing in Permanent Supportive Housing (ACP-PSH)

Advance Care Planning

United States
Accriva Diagnostics

Unknown

Clinical Performance of the Investigational GEM Hemochron® 100 in Populations Ages 18 Years and Older

Blood Coagulation Test

United States
ACADIA Pharmaceuticals Inc.

Not yet recruiting

ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study

Alzheimer's Disease Psychosis

United States
Fundacio Salut i Envelliment UAB
SUMAR empresa d'acció social de Catalunya

Unknown

Person Centered Nursing Homes: Impact Assessment Of Centered Person Care In Nursing Homes (RECENPE)

Quality of Life | Mood | Health Services for the Aged

Spain
University of Aarhus
Danish Cancer Society; TrygFonden, Denmark

Unknown

Advance Care Planning: A Way to Improve End-of-life Care Life Care

Heart Failure | Neoplasms | Pulmonary Disease

Denmark
University of New England
University of Iowa

Completed

Efficacy of CPP-ACP on Bleaching Related Sensitivity

Tooth Discoloration | Teeth Sensitivity

United States
Salus Ltd.
TheraVitae Ltd.

Completed

Autologous Angiogenic Cell Precursors (ACPs) for the Treatment of Peripheral Artery Disease

Critical Limb Ischemia

Hungary
University of California, Los Angeles
National Institute of Mental Health (NIMH)

Completed

Attention Training for Childhood Obsessive Compulsive Disorder (AMP-OCD)

Obsessive Compulsive Disorder

United States
Massachusetts General Hospital

Recruiting

ACP Video Intervention for Patients With Life-Limiting Illness

Health Care Utilization | End Stage Disease

United States
Hemostemix

Completed

ACP-01 in Patients With Critical Limb Ischemia

Critical Limb Ischemia

United States, Canada
Istituto Ortopedico Rizzoli

Completed

Intra-operative Injection of Autologous Conditioned Plasma (ACP) Following Partial Meniscectomy (ACP-MEN)

Meniscectomy

Italy
Brown University
Massachusetts General Hospital; National Institute on Aging (NIA); Hebrew SeniorLife and other collaborators

Completed

Pragmatic Trial of Video Education in Nursing Homes (PROVEN)

Heart Failure | Pulmonary Disease, Chronic Obstructive | Dementia | Alzheimer Disease

United States
San Diego State University

Completed

Advance Care Planning for Older Latinos With Chronic Illness

Communication | Chronic Disease | Patient Engagement | End of Life

United States
Indiana University
National Institute on Aging (NIA); Regenstrief Institute, Inc.; Hebrew SeniorLife

Completed

Aligning Patient Preferences: a Role Offering Alzheimer's Patients, Caregivers, and Healthcare Providers Education and Support (APPROACHES)

Dementia | Alzheimer Disease

United States
Kaohsiung Medical University Chung-Ho Memorial...

Completed

ACP Simulation-based Communication Training Program for Nurses Discussing ACP With Chronic Kidney Disease Patients

Chronic Kidney Diseases

Taiwan
Korea University Anam Hospital
Ulsan University Hospital; Gachon University Gil Medical Center; Severance Hospital and other collaborators

Completed

LAAO With DAPT Versus Antithrombotic Therapy

Coronary Artery Disease | Atrial Fibrillation

Search clinical trials for: ACP-104

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations